Drug Shortage Report for GALLIUM (GA67) CITRATE INJECTION
| Report ID | 225852 |
| Drug Identification Number | 02327813 |
| Brand name | GALLIUM (GA67) CITRATE INJECTION |
| Common or Proper name | Gallium (Ga 67) Citrate injection |
| Company Name | CURIUM CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | GALLIUM CITRATE GA 67 |
| Strength(s) | 74MBq |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 10ml |
| ATC code | V09HX |
| ATC description | |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2024-04-21 |
| Actual start date | 2024-04-21 |
| Estimated end date | 2024-04-28 |
| Actual end date | 2024-04-28 |
| Shortage status | Resolved |
| Updated date | 2024-04-29 |
| Company comments | Due to lower than anticipated yields of Ga-67 raw material, we are unable to meet total market demand for Gallium Citrate Ga 67 Injection shipping Apr 21-25, 2024. We apologize for any inconvenience caused by this issue. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2572 BOUL. DANIEL-JOHNSON LAVAL, QUEBEC CANADA H7T 2R3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2024-04-29 | French | Compare |
| v3 | 2024-04-29 | English | Compare |
| v2 | 2024-04-22 | French | Compare |
| v1 | 2024-04-22 | English | Compare |
Showing 1 to 4 of 4